Call Us Sign-Up/Sign-In
Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

iCrowdNewswire Jan 18, 2021 5:10 AM ET

Polyp Biopsy Market Overview, Dynamics, Supply & Demand, Analysis & Forecast by 2022


Polyp Biopsy Market Overview, Dynamics, Supply & Demand, Analysis & Forecast by 2022

iCrowd Newswire - Jan 18, 2021

Global Polyp biopsy Market – Overview

Most of the medical conditions, including all cases of cancer must be diagnosed by taking a sample of tissue from the individual and sending it to a pathologist for diagnosis. This process is called biopsy. Polyps are normally found in organs with many blood vessels, organs include the uterus, colon, and nose. The global Polyp Biopsy Market is expected to grow at a steady growth during the forecast period 2017-2022. The major factors influencing the growth of the market include rising consumption of tobacco and alcohol within the individuals, increasing prevalence of cancer across the globe and various others. The market is forecasted to demonstrate a single digit growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period 2017 – 2022.

Angiotech (Canada), Cardinal Health, Inc. (U.S), Carefusion Corporation (U.S), Cigna (U.S), C.R. Bard, Inc. (U.S), Devicor Medical Products Inc. (U.S), DTR Medical (Germany), Hologic, Inc. (U.S), INRAD Inc. (U.S), Olympus (Japan), and Caris Life Sciences (U.S) are some of the prominent players at the forefront of competition in the Global Polyp Biopsy Market and are profiled in MRFR Analysis.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/1673

Global Polyp Biopsy Market – Competitive Analysis

Characterized by the presence of several well-established and small players, the global market of polyp biopsy appears to be highly competitive and fragmented. With well-established market in the North America region major companies have their home in the region and generate maximum market share. These companies have expanded their operating unit in various other emerging regions as well. Moreover the other small and medium scale players are generating revenue from local market.

The market for biopsy has be highly competitive across the globe. Due to highly competitive are introducing new technology in for the development of the products. Caris Life Sciences one of the leading biotechnology company involved in manufacturing precision medicine, in December 2015 showcased the results from its first study using its revolutionary technology called Adaptive Dynamic Artificial Poly-ligand Targeting (ADAPT). The study presented, shows contains of blood plasma circulating complexes which contain information that could help as a diagnostic adjunct to mammography in women with dense breast tissue. In late 2015, outcomes from show that ADAPT is equally effective in difficult cases for which imaging technologies are inadequate for illustrating breast tissue as cancerous or non-cancerous. The ADAPT platform was developed on a huge library of approximately 1015 oligonucleotides engineered to adopt a highly complex set of unique three-dimensional binding sites. By introducing this technology will enhance the optimization of the aptamer library and testing on supplementary samples

Access Report Details @ https://www.marketresearchfuture.com/reports/polyp-biopsy-market-1673

Global Polyp Biopsy Market – Regional Analysis

The global market is segmented into the various regions including Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas accounts for the largest market share of about more than ~40%. This large share can be attributed to favourable governmental conditions for research and development. CRC is the 3rd most common cancer and the third leading cause of cancer death in the United States. There has been increasing prevalence of adenomatous polyps of the colon and rectum both in the United States and various European countries.

Europe is the second largest market of polyp biopsy. Europe saw a high prevalent cases in the incidence of colorectal cancer (CRC) along with the over-all aging population as a whole. It has been found that there were more than 375,000 cases diagnosed and more than 203,000 deaths from this disease every year, making Europe’s the second most common cancer diagnosed patients and second most common cause of death due to cancer following lung cancer.

Asia Pacific due to raising of funds for research and development activities, and growing government initiatives for the awareness and preventive cancer. Asia Pacific is the fastest growing region in the global market. Particularly, India and China are anticipated to be a growing and the fastest growing market due to improvement in healthcare domain and increasing prevalence of cancer related diseases. Many major players seeking opportunity and expand their presence in this region influencing the growth of the market.

The Middle East & Africa holds the least share in the polyp biopsy market due to lack of awareness, less emphasis on research and development activities, and poor medical facilities.

Contact Information:

Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com






Keywords:    Polyp Biopsy Market, Polyp Biopsy Market Size, Polyp Biopsy Market Share, Polyp Biopsy Market Trends, Polyp Biopsy Market Analysis, Polyp Biopsy Market Growth

Tags:    Reportedtimes, iCN Internal Distribution, Research Newswire, English